OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Reflector is Pharm Exec's Brussels correspondent.
Looks to address disconnect between registration and reimbursement.
Lack of IP management plagues recent regulatory discussions.
Committee struggles to find a common treatment approach.
New EU initiative aims to curve shortage of vaccines and therapies.
Treatment availability for rare disease patients under fire in Europe.
Report claims an imbalance in influence of tech-transfer decisions.